An unknown mechanistic insight into how analgesics promote weight loss: Paracetamol (4-Hydroxyacetanilide) inhibits hepatic steatosis and promotes weight loss via down regulation of Nocturnin, 23/February/2015, 15.49

An unknown mechanistic insight into how analgesics normalize glucose levels: Paracetamol (4-Hydroxyacetanilide) inhibits gluconeogenesis and hyperglycemia via up regulation of Cyclin D1, 24/February/2015, 13.49
February 24, 2015
Natural product-based therapy for Metastatic tumors: Bicalutamide, an androgen receptor antagonist, suppresses the expression of PD-1, a suppressor of activation of T-cells, and activates the immune system via down regulation of its target gene, 24/February/2015, 18.48
February 24, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., An unknown mechanistic insight into how analgesics promote weight loss: Paracetamol (4-Hydroxyacetanilide) inhibits hepatic steatosis and  promotes weight loss via down regulation of Nocturnin, 23/February/2015, 15.49, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that, Paracetamol (4-Hydroxyacetanilide), by increasing the expression of its target gene, it may decrease the expression of Nocturnin, and thereby promote weight loss.  Thus, pharmacological formulations encompassing Paracetamol (4-Hydroxyacetanilide) or its analogues (free of side effects)  in non-lethal doses may be used to promote weight loss.
Undisclosed information: How  Paracetamol (4-Hydroxyacetanilide) suppresses the expression of Nocturnin
Amount: $500*
* Research cooperation

Comments are closed.